2011China Modern MedicineRequires access

Effects of simvastatin on C-reactive protein and blood lipid level in patients with coronary heart disease

Bing Wang

Open publisher page 0 citations

Abstract

Objective:To detect the effect of simvastatin on C-reactive protein(CRP) and blood lipid level in patients with coronary heart disease.Methods:76 patients with coronary heart disease were randomly divided into experimental group(40 cases) and control group(36 cases).All patients received conventional treatment.On the base of these measures,the experimental group received simvastatin 20 mg per night.All patients were treated for 12 weeks.TC,TG,LDL-C,HDL-C and CRP were observed.Adverse event was recorded.Results:TC,TG,LDL-C and CRP were all reduced in experimental group significantly(P0.05).In the experimental group,TC,LDL-C and CRP were lower than that in control group(P0.05).The adverse reaction with experimental group was lower than control group(P0.05).Conclusion:Simvastatin can reduce CRP in patients with coronary heart disease.It can inhibit inflammation and has good effect on controlling blood lipid level.It is effective in reducing the potential exposure to cardiovascular events.

About this research paper

What this paper is about

Objective:To detect the effect of simvastatin on C-reactive protein(CRP) and blood lipid level in patients with coronary heart disease.Methods:76 patients with coronary heart disease were randomly divided into experimental group(40 cases) and control group(36 cases).All patients received conventional treatment.On the base of these measures,the experimental group received simvastatin 20 mg per night.All patients were treated for 12 weeks.TC,TG,LDL-C,HDL-C and CRP were observed.Adverse event was recorded.Results:TC,TG,LDL-C and CRP were all reduced in experimental group significantly(P0.05).In the experimental group,TC,LDL-C and CRP were lower than that in control group(P0.05).The adverse reaction with experimental group was lower than control group(P0.05).Conclusion:Simvastatin can reduce CRP in patients with coronary heart disease.It can inhibit inflammation and has good effect on controlling blood lipid level.It is effective in reducing the potential exposure to cardiovascular events.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To detect the effect of simvastatin on C-reactive protein(CRP) and blood lipid level in patients with coronary heart disease.Methods:76 patients with coronary heart disease were randomly divided into experimental group(40 cases) and control group(36 cases).All patients received conventional treatment.On the base of these measures,the experimental group received simvastatin 20 mg per night.All patients were treated for 12 weeks.TC,TG,LDL-C,HDL-C and CRP were observed.Adverse event was recorded.Results:TC,TG,LDL-C and CRP were all reduced in experimental group significantly(P0.05).In the experimental group,TC,LDL-C and CRP were lower than that in control group(P0.05).The adverse reaction with experimental group was lower than control group(P0.05).Conclusion:Simvastatin can reduce CRP in patients with coronary heart disease.It can inhibit inflammation and has good effect on controlling blood lipid level.It is effective in reducing the potential exposure to cardiovascular events.

Key concepts: Simvastatin, Medicine, C-reactive protein, Coronary heart disease, Internal medicine, Adverse effect, Blood lipids, Cardiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of simvastatin on C-reactive protein and blood lipid level in patients with coronary heart disease — Research Paper | ScholarLens